Relative survival and excess mortality following primary percutaneous coronary intervention for ST-elevation

Richard A Brogan1, Oras Alabas1, Sami Almudarra1

  • 11 MRC Medical Bioinformatics Centre, University of Leeds, UK.

Insights

Primary percutaneous coronary intervention for ST-elevation myocardial infarction offers excellent survival, but age and comorbidities increase long-term mortality risk. Accounting for non-cardiovascular deaths is crucial for accurate efficacy assessment.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • High survival rates are reported after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI).
  • Contemporary studies often report overall survival, potentially masking long-term risks.

Purpose of the Study:

  • To assess long-term survival after primary PCI for STEMI, adjusting for non-cardiovascular deaths.
  • To identify factors associated with poor long-term outcomes following primary PCI for STEMI.

Main Methods:

  • Utilized the UK Percutaneous Coronary Intervention registry (n=88,188, 2005-2013).
  • Matched PCI cases with UK mortality data to calculate relative survival.
  • Analyzed factors associated with excess mortality.

Main Results:

  • Crude five-year relative survival was 87.1%.
  • Increasing age, cardiogenic shock, renal failure, left main stem stenosis, diabetes, previous myocardial infarction, and female sex were associated with excess mortality.
  • Stent deployment (especially drug-eluting stents), radial access, and previous PCI were protective.

Conclusions:

  • Long-term cardiovascular survival after primary PCI for STEMI is excellent.
  • Failure to account for non-cardiovascular deaths may underestimate primary PCI efficacy.
  • Age and specific comorbidities significantly impact long-term outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
334
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
337
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
535